Abstract: Sepsis, a dysregulated immune system response to infection, is among the leading causes of morbidity, mortality, and cost overruns in the Intensive Care Unit (ICU). Early prediction of sepsis can improve situational awareness amongst clinicians and facilitate timely, protective interventions. While the application of predictive analytics in ICU patients has shown early promising results, much of the work has been encumbered by high false-alarm rates. Efforts to improve specificity have been limited by several factors, most notably the difficulty of labeling sepsis onset time and the low prevalence of septic-events in the ICU. Here, we present DeepAISE (Deep Artificial Intelligence Sepsis Expert), a recurrent neural survival model for the early prediction of sepsis. We show that by coupling a clinical criterion for defining sepsis onset time with a treatment policy (e.g., initiation of antibiotics within one hour of meeting the criterion), one may rank the relative utility of various criteria through offline policy evaluation. Given the optimal criterion, DeepAISE automatically learns predictive features related to higher-order interactions and temporal patterns among clinical risk factors that maximize the data likelihood of observed time to septic events. DeepAISE has been incorporated into a clinical workflow, which provides real-time hourly sepsis risk scores. A comparative study of four baseline models indicates that DeepAISE produces the most accurate predictions (AUC=0.90 and 0.87) and the lowest false alarm rates (FAR=0.20 and 0.26) in two separate cohorts (internal and external, respectively), while simultaneously producing interpretable representations of the clinical time series and risk factors.
Introduction
Sepsis is a syndromic, life-threatening condition that arises when the body's response to infection injures its own internal organs (1) . Though the condition lacks the same public notoriety as other conditions like heart attacks, 6% of all hospitalized patients in the United States carry a primary diagnosis of sepsis as compared to 2.5% for the latter (2) . When all hospital deaths are ultimately considered, nearly 35% are attributable to sepsis (2) . This condition stands in stark contrast to heart attacks which have a mortality rate of 2.7-9.6% and only cost the US $12.1 billion annually, roughly half of the cost of sepsis (3) .
Starting in 2004 the Surviving Sepsis Campaign (SSC) began addressing the variations in clinical
treatment regimens for sepsis and septic shock through the promulgation of evidence based practice guidelines called "sepsis bundles" (4) . These bundles consolidate the results of numerous investigations that have repeatedly demonstrated improvement in sepsis outcomes after the timely administration of broad-spectrum antibiotics, Intravenous (IV) fluids, and vasopressors when indicated (5) (6) (7) (8) . The most recent recommendation from the SSC is a 1-hr bundle that in addition to obtaining diagnostic tests like cultures and lactate levels, prescribes standard treatment with broad spectrum antibiotics, IV fluid, and vasoactive drugs if necessary, all within an hour of a sepsis diagnosis (9) . While there are effective protocols for treating sepsis once it has been diagnosed there still exists challenges in reliably identifying septic patients early in their course.
In recent years, the increased adoption of electronic medical records (EHRs) in hospitals (10) has motivated the development of machine learning based surveillance tools for detection or classification (11) (12) (13) (14) (15) and prediction (11, (16) (17) (18) (17, 18) have focused on developing models to predict septic shock, which occurs when sepsis leads to low blood pressure that persists despite treatment with intravenous fluids. However, a direct comparison of these methods is not possible for several reasons: 1) utilization of different labels for sepsis and septic shock, 2) variations in prediction horizon (finite horizon prediction vs infinite horizon prediction, 3) differences in frequency of prediction (single event classification vs sequential prediction), and 4) variations in study design and disease prevalence (case-control design vs calibrated real-world prevalence models). To date most sepsis prediction research has failed to make the transition into viable Clinical Decision Support (CDS) systems owing to the relatively low clinical tolerance for false-alarms (19) , as well as the interpretability and workflow integration requirements for CDS systems (20, 21) . False clinical alarms not only increase the cognitive load on clinicians but can also expose patients to unnecessary antibiotics and may contribute to emergence of antibiotic resistance pathogens (22) . Nevertheless, identifying and treating true cases of sepsis before they are clinically apparent is categorically one of the most important needs for modern medicine to address.
Consistently identifying the onset time for sepsis presents unique challenges because the condition manifests as constellation of signs and symptoms with significant variability in presentation and timing. The Third International Consensus Definitions for Sepsis (Sepsis-3) guidelines have provided two primary criteria for making a formal diagnosis of sepsis: 1) There must be a suspicion for infection (indicated by the administration of antibiotics for at least 72hrs with the concomitant collection of cultures) 2) There must be a two-point increase in the SOFA (Sequential Organ Failure Assessment) score (1) . These criteria have associated time points and from these time points, sepsis can be consistently labeled. While the Sepsis-3 criterion is considered the current standard for labeling sepsis onset time, previous consensus criteria for sepsis (based on Sepsis-1 and Sepsis-2 definitions) (23, 24) remain in wide use. Additionally, there are other sepsis criteria developed by the Center for Disease Control (CDC) and Center for Medicare and Medicaid Services (CMS) for use in surveillance studies (25, 26) .
When applied to the same patient population, the execution of aforementioned criteria often leads to significant variability in the sepsis onset times. Therefore, a question of interest is what consensus criteria for sepsis (on average) is likely to result in improved patient outcomes if coupled with appropriate treatment protocols. In this work, we show that by coupling a criterion with a treatment policy (e.g., initiation of antibiotics within an hour of meeting the criterion), one may use the framework of Attributable treatment effect estimates (ATEE) (27) to rank the relative utility of various criteria through policy evaluation. The ATEE framework allows one to ask outcome-specific counterfactual questions such as 'what-if a patient had received antibiotics 4-6 hours prior to meeting a given sepsis onset time?' or 'what-if a treatment bundle requirement was met within 3-hours of clinical recognition?'. This is equivalent to evaluating the expected reward (e.g. hospital survival or 60 days survival) associated with a counterfactual treatment policy (e.g., early detection of sepsis via an automated algorithm followed by administration of antibiotics) compared to the actual hospital policy (e.g., suspicion of sepsis by a clinician followed by administration of antibiotics).
The three primary contributions of this work are: a) An ATEE framework to compare the various consensus criteria of sepsis and choose the most optimal amongst them. b) A deep learning framework for prediction of sepsis (called DeepAISE) that reduces incidents of false alarms by automatically learning predictive features related to higherorder interactions and temporal patterns among clinical risk factors for sepsis. Unlike comparable models, this algorithm maintains interpretability by tracking the top relevant features contributing to the sepsis score as a function of time, providing clinicians with rationale for alerts. Most importantly, DeepAISE is a generalizable model developed using 25,000 patient admissions to the Intensive Care Units (ICUs) at two Emory University hospitals and over 40,000 ICU admissions from the Medical Information Mart for Intensive Care-III (MIMIC-III) ICU database. c) A software platform that integrates the DeepAISE framework with live streaming patient data, computes sepsis risk scores in real-time, and presents them in an interpretable, clinically meaningful fashion. The platform is scalable and can be integrated into clinical workflow.
Results

Study design and patient cohorts
The DeepAISE model was trained and validated on two separate patient cohorts. The Emory cohort consisted of all patients admitted to the ICUs at two hospitals within the Emory Healthcare system in Atlanta, Georgia from 2014 to 2018. External validation of the DeepAISE model was performed on the MIMIC-III database (28) , which is a publicly available database containing de-identified clinical data of patients admitted to a medical center in Boston, Massachusetts from 2001 to 2012.
The complete set of patient features (Appendix C of Supplementary Material) was grouped into three categories: clinical features (e.g. heart rate, mean arterial pressure, etc.), laboratory test results (e.g. hemoglobin, creatinine, etc.) and demographic/history/context features (e.g. age, care unit type, etc.).
In both the cohorts, the Third International Consensus Definition of Sepsis (Sepsis-3) (1, 29) criterion was used to assign sepsis onset time (tsepsis-3) when two conditions were simultaneously satisfied: 1) there was a clinical suspicion of infection (tsuspicion) and 2) there was a two point increase in SOFA score (tSOFA). Similarly, all patients were labeled for the Center for Disease Control (CDC) onset time of sepsis (tsepsis-CDC) according to a modified version of the criterion developed the CDC (25) when two conditions were simultaneously satisfied: 1) there was a clinical suspicion of infection and 2) there was an eSOFA score of one or higher (teSOFA) (30) . The labels of tsuspicion, tSOFA, tsepsis-3, teSOFA, and tsepsis-CDC are used extensively throughout this study to define key time points and are clearly described in Table 1 .
The Emory cohort consisted of a total of 25,820 patients (see Table S1 for patient characteristics), 1,445 of whom met the Sepsis-3 criterion four hours or later after ICU admission (29) . Those who developed sepsis tended to have a slightly higher percentage of male patients compared to nonseptic patients (55.2% vs. 53.2%) and had more comorbidities (Charlson Comorbidity Index [CCI] 3 vs. 2). Septic patients had longer median lengths of ICU stay (5.9 vs. 1.9 days), higher median SOFA scores (5.0 vs. 1.7), and higher hospital mortality (15.2% vs. 3.5%). The median [interquartile range (IQR)] time from ICU admission to tsepsis-3 in the Emory cohort was 24 [9, 63] hours. In comparison, the median [IQR] time from ICU admission to tsepsis-CDC in the Emory cohort was 31 [11, 70] hours. Similar patterns were observed for the MIMIC-III external validation cohort (Appendix E of Supplementary Material, Table S3 ).
Attributable treatment effect estimates
We used the framework of attributable treatment effect-size estimates (ATEE) to quantitatively compare the two aforementioned consensus criteria (namely tsepsis-3 and tsepsis-CDC) for labeling sepsis onset time (see Material and Methods for more details). We considered four different treatment levels corresponding to different antibiotic administration delay intervals with respect to the onset time of sepsis, namely [-24, -6) , [-6, 0) , [0, 3) , and [3, 24] hours. The ATEE framework was used to assess the survival effects of early or late antibiotics administration with respect to each criterion (see Table 2 ). Entries in the table correspond to expected improvement in outcome (defined as not dying or not getting transferred to a hospice) as estimated by Eq. 1. In all cases, early administration of antibiotics resulted in a net improvement in outcome, compared to the existing clinical policy. The results from Table 2 
DeepAISE prediction performance for sepsis onset
The DeepAISE model was trained to predict the early onset of sepsis (tsepsis-3). DeepAISE made hourly predictions, starting four hours after ICU admission, and considered a total of 65 features that were commonly available in the EHR. The Emory training and testing sets contained a total of approximately 500,000 and 125,000 hourly prediction windows, respectively. A complete list of all the input features is provided in Appendix C of Supplementary Material.
The DeepAISE model reliably predicted tsepsis-3 four hours in advance with an AUC of 0.90 (specificity of 0.80 at sensitivity of 0.85) on the Emory testing set. Slightly lower performance was observed for the MIMIC testing set, with the DeepAISE model achieving an AUC of 0.87 for predicting tsepsis-3 four hours in advance (see Table 3 Across all prediction windows, DeepAISE consistently outperformed all other classifiers (p<0.001; when AUC of DeepAISE was compared with AUC of other baseline methods) for prediction of tsepsis-3 (See Fig. 1, Fig. S3 and Table S2 ) and across all prediction windows, indicating that capturing temporal trends and interactions among the risk factors is important for accurate prediction of sepsis. The performance of all the models decreased with the increase in prediction horizon. For DeepAISE, the AUC on the Emory testing set decreased from 0.90 at 4-hour prediction horizon to 0.88 at 12-hour prediction horizon. We also observed that these findings were consistent with the MIMIC testing set (Fig. S8 ).
In addition, a FFNN trained to predict tsepsis-3 with delta change in SOFA score as input achieved 0.54 AUC on Emory testing set, and a FFNN trained to predict tsepsis-3 with delta change in SOFA score and static covariates (such as age, gender, weight etc.) as inputs achieved 0.68 AUC on the Emory testing set. The above results show that DeepAISE scores were not simply recapitulations of the SOFA scores.
Clinical interpretation of DeepAISE predictions
While performance characteristics of machine learning algorithms are important, providing interpretable data to the bedside clinicians that can guide diagnosis and therapeutic interventions is a critical requirement of CDS systems. To date many sepsis models have failed to demonstrate which physiologic aberrations contributed to the model's prediction, compelling many to refer to them as "black boxes" DeepAISE allayed these concerns by continually revealing the top patient features contributing to its predicted risk scores. Unlike many other algorithms, DeepAISE is uniquely interpretable as evidenced in Fig. 2 in which the trajectory of a septic patient who developed pneumonia in the ICU is displayed. In this visualization, the sepsis risk score predicted by the model is shown along with vital sign trends, and most notably, the most relevant features contributing to the risk score. In this example, early deterioration of the patient's respiratory status was detected by the model. The model identified aberrations in PaO2, PaCO2, blood pH and Glasgow coma score (GCS) as some of the top features relevant to its prediction. The importance of each feature was calculated using the magnitude and sign of the associated relevance scores, in a fashion similar to saliency maps for convolutional neural networks (32) . To validate the clinical interpretability of the DeepAISE model, analysis of the most relevant features starting 10 hours prior to and ending at tsepsis-3 was conducted (see Fig. 4 ). This investigation revealed that DeepAISE ascribed importance to several features that have already been identified as risk factors for sepsis such as recent surgery, length of ICU stay, heart rate, GCS, white blood cell count, and temperature, and some less appreciated but known factors such as Phosphorus The manifold in Fig. 3 shows that trajectories for patient 1 and 2 follow similar terminal patterns; however, correctly assigns them different starting positions with patient 2 starting from a comparatively higher risk cluster. The specific trajectory of an ICU patient may be useful in categorizing infectious phenotypes and detecting anomalous physiological dynamics.
DeepAISE user interface and tele-ICU workflow integration
The goal of any CDS system is to improve patient outcomes and reduce hospitalization costs; however, actualization of these goals is incumbent upon clinical teams embracing and actually employing the technology. The integration of a CDS system into clinical workflows depends on many factors, and therefore the development of the DeepAISE UI (User Interface) involved nursing stakeholders in our tele-ICU center.
Appreciating the workflow of the tele-ICU staff was a critical component of ensuring that the developed UI was both useable and interpretable. Nursing stakeholders identified the key tasks in the tele-ICU as consisting of the following: routine patient assessment, sepsis risk assessment, communication with the bedside clinical team, and physician initiation of therapeutic interventions. A minimal user interface (UI) that enhanced workflow awareness, provided easy actionability, and ensured data integrity was built after soliciting requirements from the aforementioned stakeholders in early 2017.
The resultant UI shown in Fig. 6 was designed to present a list of patients sorted by sepsis risk score. Square cards that include the sepsis risk score as well as the change in score over the past hour are used to represent a single patient. Individual cards can be flipped via a single mouse-click to reveal the top factors contributing to the presented score. To improve individual and unit situational awareness regarding patient interventions and assessments, users can drag-and-drop patient cards into columns representing different treatment categories.
Data integrity assessment was carried out via manual chart-review of patient records (vitals, labs, etc.) to ensure that the displayed patient data on the user interface matched the corresponding values within the clinician facing EHR application (Cerner's PowerChart). Overall, 100% of users (five out of five tele-ICU nurses) reported improvement in usability with the addition of top contributing factors to the risk score and workflow related features into the user interface.
Discussion
The major contribution of this effort is a framework for joint optimization of features (via deep learning) and labels (through counterfactual reasoning) for training predictive models in clinical settings. We showed that the ATEE framework can be used to optimally select among multiple criteria of sepsis (i.e., Sepsis-3 criterion and Sepsis-CDC criterion) while simultaneously providing an estimate of the effect size associated with early or late antibiotics administration. Moreover, a deep learning model was used to automatically learn complex features, including temporal trends and higher-order interactions among the risk factors, to accurately predict the likelihood of sepsis in patients admitted to the ICU up to 12 hours in advance. Finally, satisfaction amongst users of our CDS system was most greatly impacted by the enhancement of clinical interpretability of the findings through a workflow-aware UI that incorporated a patient's trajectory and the key factors contributing to their risk score.
DeepAISE was developed to predict two time-points of interest in this study, namely tsepsis-3 (Sepsis-3 criterion), and tsepsis-CDC (Sepsis-CDC criterion). Counterfactual reasoning indicated that there would be an approximate 8% improvement in patient survival if a clinical policy of administrating antibiotics 6-hours prior to tsepsis-3 was implemented. Note, this improvement was with respect to the actual antibiotic administration times (i.e. the clinical policy) at a tertiary academic medical center. Similar analysis revealed a marginal expected improvement in survival when considering a clinical policy based on administration of antibiotics 6-hours prior to tsepsis-CDC.
Notably, the onset time of sepsis according to the CDC criterion often occurred approximately 6-7 hours after the sepsis-3 onset time. This delay was likely attributable to the more stringent eSOFA scoring method that requires an adverse change of ≥ 50% from a patients' baseline value in order to mark an increase in individual organ scores. When considering interval of [-24, -6) hours prior to onset time of sepsis we did not observe any statistically significant difference between the expected outcomes (roughly 8% for both criteria). However, prediction of onset time of sepsis degrades with longer prediction windows and one may expect higher false alarms and lower predictive value over the [-24, -6) hours interval. We observed that the six hours ahead prediction AUC of DeepAISE (on Emory testing set) was 0.89 for tsepsis-3. Additionally, the performance of DeepAISE expectedly dropped as the prediction window increased from 2 to 12 hours. All the findings in patients were externally validated with the MIMIC-III cohort.
Another advantage of the proposed deep learning approach is in its ability to provide the top factors contributing to the risk score for every point in time for each patient (i.e., local interpretability).
The distinction between the global and local notions of interpretability (i.e., what features are contributing to the sepsis risk score for the cohort at large versus an individual patient's hourly prediction window) is most notable when dealing with models capable of capturing higher order interactions and temporal trends in the data. As a result, the degree of risk associated with a factor (e.g., temperature) is a function of other factors in a multiplicative sense (e.g., hypothermia and old age are together a greater risk factor than either by itself). Similarly, the temporal context of a risk factor can alter its contribution to a given risk score calculation (e.g., leukocytosis immediately after surgery may not be unexpected and may contribute differently to the risk for sepsis). These (30) . While it is important to design deep learning models with high performance, it is imperative to build models that provide interpretable data to bedside clinicians that can augment their understanding of the disease process and can contribute to the selection and initiation of appropriate treatments. DeepAISE was designed to be transparent by: 1) continually revealing the top causes contributing to the sepsis risk score (see Fig. 2 ), 2) providing a lower dimensional view of the patients' trajectory (see Fig. 3 ), and 3) providing a prioritized list of patients at risk for sepsis (see Fig. 6 ). These three attributes allow the bedside clinician to identify pathologic deviations from expected physiology early and in real-time throughout the duration of patients' hospital admission. Moreover, we have shown that the top causes can be broken down into two categories of positively and negatively contributing factors to the risk score (see Appendix F of supplementary material). Notably, this analysis shed insight on the input features contributing significantly to the sensitivity (positive contributors) and specificity (negative contributors) of DeepAISE (see Fig. 4 ). Since one of the key limitations of using EHR data is the intermittent nature of laboratory measurements, we hypothesize that one may use the knowledge of the top contributing factors to protocolize the ordering of laboratory tests, to ensure specific updated measurements of these factors are available to the algorithm, thus improving model sensitivity and specificity. While we have strictly adhered to the Sepsis-3 criteria for defining septic labels in our study, it has been noted that this criterion is too stringent and the sensitivity of early detection is lost to an increased specificity (36, 37) . The Sepsis-3 criterion utilized in this study is an acausal clinical construct for demarcating the onset time of sepsis, and as such cannot be used in a clinical setting for early detection of sepsis; however, a predictive analytic risk score when trained to predict the associated onset-time can combine the specificity advantages of Sepsis-3 with the benefits of early recognition. Moreover, it is critical to appreciate that making a clinical diagnosis of sepsis carries much greater value than simply identifying 'poor health' or general decompensation. Clinical outcomes have repeatedly been positively impacted by the rapid administration of broad-spectrum antibiotics, IV fluids, and vasopressors if indicated (6, 9) . The predictive ability of DeepAISE is remarkable because it means at a minimum that preparatory measures to implement sepsis bundles can begin much earlier and when appropriate, interventions like antibiotic therapy can be initiated sooner. In both instances this has an enormous potential to reduce the expected morbidity and mortality for this condition. Sepsis survivors often suffer from high rates of readmission (38) and many survivors of sepsis face life-long, debilitating sequelae as a result of the disease (39) . Future extensions of this work will involve assessing the long-term benefits of competing treatment policies using the ATEE framework. Prospective clinical trials will be necessary to confirm this supposition; however, our findings provide significant clinical evidence for a radical change to the sepsis treatment paradigm that has real-time high-dimensional data analysis and model transparency at its center.
Materials and Methods
Study design
We performed a retrospective study of all patients admitted to the ICUs at two hospitals within the The Emory cohort contained a total of 25,820 patients, 1,445 of whom met the Sepsis-3 criterion four hours or later after ICU admission. Out of the 25,820 patients, 70% of them were used for developing the model (training set), 10% were used for hyper-parameter optimization, and the remaining 20% formed the testing set (see Table S6 for a description of the various holdout datasets that have been used for analysis in this paper). The Emory training set contained a total of 18,074 patients out of which 1,003 patients met the Sepsis-3 criterion, and the Emory testing set contained a total of 5,165 patients out of which 287 patients met the Sepsis-3 criterion during their stay in the ICU. The MIMIC-III external validation cohort was split in a similar fashion, and more details can be found in the Appendix E of Supplementary Material. The DeepAISE model was trained and evaluated on both the Emory cohort and the MIMIC-III external validation cohort separately.
Attributable treatment effect estimates (ATEE)
We first defined a sepsis treatment policy ( "
,dk}, as initiation of antibiotics within t hours of meeting the criterion (e.g., tsepsis-3 or tsepsis-CDC), with l ∈ L = {l1, l2, …, lm}, taking either positive or negative values (we take t to belong to an interval l). We considered four different antibiotics administration intervals, namely [-24, -6) , [-6, 0) , [0, 3) , and [3, 24] hours, corresponding to l1, …, l4, respectively (See Fig. S10 ). For the purpose of ATEE analysis, these intervals at the corresponding lags or delays in antibiotics administration were considered as treatment levels.
The propensity score was first introduced as a statistical tool in observational studies to select a control cohort for treatment effect estimation for binary treatments and binary outcomes (40) . The method of Generalized Propensity Score (GPS) was developed to extend effect estimation to the case of multi-level (or categorical) treatments. More formally, the GPS is the conditional probability that the n-th individual with covariates C (n) receives a treatment level, where C (n) corresponds to the n-th patient's covariates measured prior to administration of antibiotics.
The propensity to receive a given level of treatment l (e.g. antibiotics within three hours of tsepsis- 3) , denoted by ( * (-) /, was then modeled using a multi-class feedforward neural network (namely the GPS-network, see Fig. S11(a) ), where given the set of covariates C (n) prior to administration of antibiotics, the model returned the patients' propensity to receive a treatment level, l. This propensity score enabled us to assess the effects of a given treatment level on the patient outcome (Y), through causal inference with discrete treatment levels and binary outcomes (41, 42) . Creating an averaged dose response function (ADRF) by mapping the received treatment levels and the associated GPS to the outcome of interest (e.g., hospital survival) allowed us to explore counterfactual reasoning for timing of antibiotics. That is, 'how might a patient's outcome change if the patient was given levels of treatment different from the hospital policy?'. The ADRF function was modeled through another feedforward neural network (namely the survival network, see Fig. S11(b) ), followed by isotonic least squares regression to ensure calibrated estimates of outcomes. The input to the ADRF network was a combination of the one-hot encoded vector of the treatment level, and the GPS corresponding to the treatment level.
Given a set of clinical observations and a counterfactual level of treatment, the GPS-network was first used to map the observations to GPS scores for the actual and counterfactual treatment levels.
Next, the GPS scores and the actual and counterfactual treatment levels were separately fed into the ADRF model to estimate the expected effect size (Δ( " # )) associated with a given policy and treatment level:
where the first term inside the parentheses on the right-hand-side of the question was the propensity adjusted expected survival associated with the counterfactual treatment level l, and the second term was the propensity adjusted expected survival associated with the actual treatment level, ;< (-) for patient n. For each criterion and treatment level, we trained the GPS and ADRF networks 50 times, using random initialization of network parameters, to obtain confidence intervals for our estimation of Eq. 1.
Development of the DeepAISE model
DeepAISE began producing scores four hours after ICU admission, and it was designed to predict (on an hourly basis) the probability of onset of sepsis within the next 2, 4, 6, 8, 10 and 12 hours.
The two distinct characteristics of the model were a) utilization of a class of deep learning algorithms for multivariate time series data known as the Gated Recurrent Unit (GRU) that allows for modeling the clinical trajectory of a patient over time (38) , and b) deployment of a parametric survival model called the Weibull Cox proportional hazards (WCPH), which casts the problem of sepsis prediction to a time-to-event prediction framework and allows for handling of right censored outcomes (16), using the features learned from the underlying GRU model. The parametric survival model allows for efficient end-to-end learning of the GRU and the WCPH parameters using standard deep learning optimization techniques (43) .
In preparation for time series modeling, the longitudinal data of patients were binned into consecutive windows of 1-hour duration, with the survival data for each of the time bins comprising of three elements: a set of input features x, the time to sepsis event and sepsis event indicator e. If a sepsis event occurred within the prediction horizon, the time interval would correspond to the duration of time between the time at which sepsis event occurred and the time of collection of features x, with the sepsis event indicator e set to 1. If sepsis did not occur within the prediction horizon, the time interval would correspond to one hour more than the duration of the prediction horizon, with the sepsis event indicator e set to 0 (i.e., a right-censored event).
Instead of feeding the features of a patient directly to a WCPH model, we first fed the longitudinal data of patients into a GRU model followed by a feedforward neural network (FFNN) to learn a representation of patient's trajectory at the current time-step, which was then fed to the WCPH 
In the above equation, ( G ) denotes the output from the GRU-FFNN module, represents the patient-specific hazard parameters, >0 was a scale parameter and >0 was a shape parameter for provided the probability of not getting sepsis over the prediction horizon. The predicted probability of the sepsis event occurring within the prediction horizon was then defined as one minus the survival score.
Model evaluation and statistical analysis
For all continuous variables, we have reported median ([25th -75th percentile]) and used a twosided Wilcoxon rank-sum test when comparing two populations. For binary variables, we have reported percentages and use a two-sided chi-square test to assess differences in proportions between two populations. The area under receiver operating characteristic (AUC) curves statistics, specificity (1-false alarm rate) and accuracy at a fixed 85% sensitivity level were calculated to measure the performance of the models. We have reported the DeepAISE performance results for four hours ahead prediction for both the training set and testing set on the Emory cohort and the MIMIC-III external validation cohort. Additionally, we have also reported the performance results L2 regularization parameter were optimized using Bayesian optimization (46) . All pre-processing of the data was performed using Numpy (47) , with the rest of the pipeline implemented using
TensorFlow (48) .
Testing the validity of the relevance scores and model interpretability
For a given risk score calculation the contribution of the individual input features was calculated using the associated relevance scores, by calculating the gradient of the sepsis risk score with respect to all input features and element-wise multiplication by the corresponding input features.
The resultant scores, also known as the relevance scores, were then z-scored and the top 10 features (i.e., most frequently observed features across patients and across time) with a z-score of larger 
Real-time implementation details
To facilitate real-time decision support with DeepAISE, a software platform was developed. The and for whom no immediate action was deemed necessary (see Fig.6 , 'Snoozed Alarms' column). Situational awareness was further improved by the movement of septic patients to a third column (see Fig.6 , 'Treatment Initiated' column) indicating that a sepsis related treatment had been initiated.
A web-based version of the DeepAISE software pipeline, with anonymized data, is currently available in demo-mode (https://sepsis.app/ ; username:demo, password:demo). when global feature replacement analysis and local feature replacement analysis were performed for features with positive relevance score (left subfigure; see Table S4 ) and negative relavance score (right subfigure; see Table S5 ). The scores are then managed by a time series database in the Results Database Service (4), which provides the required data for the UI implemented using client-side Javascript. The figure inset shows a live integration of DeepAISE UI in a tele-ICU workflow. tSOFA The occurrence of end organ damage as identified by a two-point deterioration in SOFA score within a 6-hour period
tsepsis-3
The onset time of sepsis-3 is marked when both tsuspicion and tSOFA have happened within close proximity to each other. Specifically, tSOFA must occur 24 hours before tsuspicion or up to 12 hours after the tsuspicion (tSOFA + 24 hours > tsuspicion > tSOFA -12 hours). The earlier of the tSOFA or tsuspicion was assigned to tsepsis.
teSOFA The occurrence of end organ damage as identified by one point or higher eSOFA score within a 6-hour period
tsepsis-CDC
The onset time of sepsis-CDC is marked when both tsuspicion and teSOFA have happened within close proximity to each other. Specifically, teSOFA must occur 24 hours before tsuspicion or up to 12 hours after the tsuspicion (teSOFA + 24 hours > tsuspicion > teSOFA -12 hours). The earlier of the teSOFA or tsuspicion was assigned to tsepsis-CDC. 
